Literature DB >> 21203360

What is Known About the Association of Antinuclear Antibodies Development During Treatment with TNF Blockers?

Mark Lebwohl1.   

Abstract

Entities:  

Year:  2008        PMID： 21203360      PMCID： PMC3013593     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN： 1941-2789


× No keyword cloud information.
  7 in total

1.  Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab.

Authors:  Míriam Mañosa; Eugeni Domènech; Laura Marín; Alejandro Olivé; Yamile Zabana; Eduard Cabré; Miquel A Gassull
Journal:  Gut       Date:  2008-04       Impact factor: 23.059

2.  Infliximab-induced lupus-like syndrome associated with autoimmune hepatitis.

Authors:  M Marques; F Magro; H Cardoso; F Carneiro; R Portugal; J Lopes; C Costa Santos
Journal:  Inflamm Bowel Dis       Date:  2008-05       Impact factor: 5.325

3.  Drug-induced systemic lupus erythematosus associated with etanercept therapy.

Authors:  Najia Shakoor; Margaret Michalska; Charlotte A Harris; Joel A Block
Journal:  Lancet       Date:  2002-02-16       Impact factor: 79.321

Review 4.  Autoimmunity and anti-TNF-alpha agents.

Authors:  Fabiola Atzeni; Maurizio Turiel; Franco Capsoni; Andrea Doria; Pierluigi Meroni; Piercarlo Sarzi-Puttini
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

5.  From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis.

Authors:  Mark Lebwohl; Jerry Bagel; Joel M Gelfand; Dafna Gladman; Kenneth B Gordon; Sylvia Hsu; Robert E Kalb; Alexa Boer Kimball; Neil J Korman; Gerald G Krueger; Philip Mease; Warwick L Morison; Amy Paller; David M Pariser; Christopher Ritchlin; Bruce Strober; Abby Van Voorhees; Gerald D Weinstein; Melodie Young; Liz Horn
Journal:  J Am Acad Dermatol       Date:  2007-11-05       Impact factor: 11.527

6.  Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study.

Authors:  Martin Aringer; Winfried B Graninger; Günter Steiner; Josef S Smolen
Journal:  Arthritis Rheum       Date:  2004-10

Review 7.  Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention.

Authors:  M Aringer; J S Smolen
Journal:  Lupus       Date:  2004       Impact factor: 2.911
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.